Penumbra PEN
NYSE PEN
$324.99 -1.85 (-0.57%)
At close: Aug 20, 2026 · 1:18 PM UTC

Penumbra (PEN) Liabilities and Shareholders Equity (2014 - 2026)

Penumbra (PEN) posted quarterly Liabilities and Shareholders Equity of $2.0 billion for Q2 2026, up 17.91% year-over-year from $1.7 billion in Q2 2025, and up 4.02% quarter-over-quarter from $1.9 billion in Q1 2026.

Penumbra (PEN) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Penumbra (PEN) has reported Liabilities and Shareholders Equity for 13 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity rose 17.91% year-over-year to $2.0 billion; the TTM figure through Jun 2026 stood at $7.4 billion (up 18.53% YoY), while the FY2025 annual figure was $1.8 billion, up 19.13% from the prior year.
  • Liabilities and Shareholders Equity climbed to $2.0 billion in Q2 2026 per PEN's latest filing, from $1.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.0 billion in Q2 2026 and bottomed at $1.3 billion in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2024.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 54.8% — and 2024, when it retreated 1.49%.
  • Penumbra's Liabilities and Shareholders Equity stood at $1.4 billion in 2022, then advanced by 13.53% to $1.6 billion in 2023, then retreated by 1.49% to $1.5 billion in 2024, then gained by 19.13% to $1.8 billion in 2025, then grew by 8.11% to $2.0 billion in 2026.
  • Business Quant data shows PEN's Liabilities and Shareholders Equity at $2.0 billion in Q2 2026, $1.9 billion in Q1 2026, and $1.8 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn 109.22 Bn
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 31.04 Bn
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 10.74 Bn
10 Penumbra 12.79 Bn 12.13 Bn 264.94 Mn 1.97 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.97 Bn
Mar 31, 2026 1.90 Bn
Dec 31, 2025 1.83 Bn
Sep 30, 2025 1.74 Bn
Jun 30, 2025 1.67 Bn
Mar 31, 2025 1.59 Bn
Dec 31, 2024 1.53 Bn
Sep 30, 2024 1.48 Bn
Jun 30, 2024 1.53 Bn
Mar 31, 2024 1.58 Bn
Dec 31, 2023 1.56 Bn
Sep 30, 2023 1.47 Bn
Jun 30, 2023 1.43 Bn
Mar 31, 2023 1.40 Bn
Dec 31, 2022 1.37 Bn
Sep 30, 2022 1.32 Bn
Jun 30, 2022 1.33 Bn
Mar 31, 2022 1.30 Bn
Dec 31, 2021 1.24 Bn
Sep 30, 2021 973.24 Mn